Today: 9 April 2026
Subscribe
Browse Category

NASDAQ:CAI 30 December 2025 - 12 January 2026

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Caris Life Sciences shares fell 8.5% to $26.08 in afternoon trading after the company reported preliminary 2025 revenue near $800 million, up 94%, but warned of significant prior-period adjustments. The company also announced a partnership with Everlywell to develop a blood-based early cancer detection test, with more details expected at the JPMorgan Healthcare Conference later Monday.
12 January 2026
··
Why Caris Life Sciences (CAI) stock is down today as biotech slips

Why Caris Life Sciences (CAI) stock is down today as biotech slips

Caris Life Sciences shares fell 1.8% to $27.44 by 2:41 p.m. ET Tuesday, underperforming biotech peers as sector benchmarks declined. The drop followed recent attention on Caris’ Genentech partnership, which includes $25 million upfront and up to $1.1 billion in potential milestones. The S&P 500 and Nasdaq were flat. Investors are watching Caris’ test volumes and revenue guidance.
30 December 2025

Stock Market Today

  • Morgan Stanley's Ridham Desai Predicts Sensex at 95,000 by Dec 2026 Amid Bull Market Signal
    April 9, 2026, 6:01 AM EDT. Morgan Stanley strategist Ridham Desai forecasts the Sensex could reach 95,000 by December 2026, marking a 22% gain from the current level of 77,563. This target reflects a valuation at 23.5 times trailing earnings, slightly above the historical average of 22 times. The firm highlights India's nearly worst 12-month relative stock performance in history but notes a potential market recovery driven by stable macroeconomic factors, earnings growth, and steady policy environment. Key growth drivers include fiscal discipline, private investment, and robust domestic demand. The bull scenario sees the index soaring to 107,000 on stronger growth and lower oil prices, while risks such as high crude prices and a potential US recession could drag it down to 76,000. Overall, Indian equities appear undervalued and positioned for a rebound according to Morgan Stanley.

Latest article

Australia Stock Market Today: ASX 200 Ends at Five-Week High as Banks Offset Tech Rout

Australia Stock Market Today: ASX 200 Ends at Five-Week High as Banks Offset Tech Rout

9 April 2026
The S&P/ASX 200 closed up 0.2% at 8,973.20 on Thursday, a five-week high, led by gains in banks while tech shares slumped. Bendigo and Adelaide Bank surged 9.5% after reporting higher earnings and job cuts. Energy stocks rose as oil rebounded, but trading volumes stayed below average. Investors remained cautious amid ongoing Middle East tensions and uncertain oil supply routes.
UK Stock Market Today: FTSE 100 Holds Near 10,600 as Oil Rebound Tests Ceasefire Rally

UK Stock Market Today: FTSE 100 Holds Near 10,600 as Oil Rebound Tests Ceasefire Rally

9 April 2026
FTSE 100 held near 10,600 Thursday after a 2.5% rally to a one-month high, outperforming European peers as Germany’s DAX and France’s CAC 40 fell. Brent crude rebounded toward $98 on renewed U.S.-Iran ceasefire doubts. A Bank of England survey showed lenders expect mortgage demand to rise in Q2. British builders faced record cost inflation in March.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 6:12 AM EDT Morgan Stanley's Ridham Desai Predicts Sensex at 95,000 by Dec 2026 Amid Bull Market Signal April 9, 2026, 6:01 AM EDT. Morgan Stanley strategist Ridham Desai forecasts the Sensex could reach **95,000 by December 2026**, marking a 22% gain from the current level of 77,563. This target reflects a valuation at 23.5 times trailing earnings, slightly above the historical average of 22 times. The firm highlights India's nearly worst 12-month relative stock performance in history but notes a potential market recovery driven by stable macroeconomic
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Go toTop